AKT3 and α-SMA in oral submucous fibrosis and oral squamous cell carcinoma with concomitant oral submucous fibrosis as potential prognostic indicators
Journal of Oral and Maxillofacial Pathology · 2026-04 · 30 (2) · 186-193
DOI: 10.4103/jomfp.jomfp_400_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral and Maxillofacial Pathology, online erschienen am 03.07.2026. Verfasst von Sonali Behera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Pathology, SCB Govt. Dental College and Hospital, Cuttack, Odisha, India. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Oral squamous cell carcinoma (OSCC) concomitant with oral submucous fibrosis (OSCC-OSMF) is a clinico-pathologically distinct entity. Myofibroblasts (MFs) and its differentiation plays pivotal role in tumour progression via cell cycle alterations, epithelial–mesenchymal transition (EMT), hypoxia, immunomodulatory disorders, oxidative injury and epigenetic modifications.
Objective
The present study evaluated immunohistochemical expression of AKT3 and alpha-smooth muscle actin amongst, OSMF and OSCC-OSMF and correlated with related clinicopathological parameters. Materials and Methods: 70 formalin-fixed paraffin-embedded tissue samples of histopathologically confirmed cases, including 10 NOM, 30 OSMF, and 30 OSCC-OSMF, were immunohistochemically stained with AKT3 and (α-SMA) antibodies to quantify MFs and myofibroblastic cancer associated myofibroblasts (myCAFs).
Results
The percentage of α-SMA and AKT3 positive cells was statistically significant within the OSMF and OSCC-OSMF study groups ( P < 0.0001). A progressive increase in cytoplasmic expression of α-SMA and AKT3 was observed from NOM to OSMF and OSCC-OSMF. A statistically significant correlation was found between the stages of OSMF and the clinical TNM stages of OSCC-OSMF.
Conclusion
Increased stromal expression of α-SMA and AKT3 is associated with disease progression in OSMF and OSCC-OSMF. This is the first study to investigate AKT-3 expression in OSMF and OSCC arising in OSMF, and these markers may serve as potential indicators of stromal activation and tumour progression, thereby warranting further longitudinal and functional investigations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Pathology, SCB Govt. Dental College and Hospital, Cuttack, Odisha, India.
- Department of Oral Medicine and Radiology, Kalinga Institute of Dental Sciences, KIIT Deemed to be University, Bhubaneswar, Odisha, India.
Zitieren
APA
Behera, S., Rath, R., Das, S. N., Mohanty, A., Nanda, A., & Behera, S. (2026). AKT3 and α-SMA in oral submucous fibrosis and oral squamous cell carcinoma with concomitant oral submucous fibrosis as potential prognostic indicators. Journal of Oral and Maxillofacial Pathology, 30(2), 186-193. https://doi.org/10.4103/jomfp.jomfp_400_25
Vancouver
Behera S, Rath R, Das SN, Mohanty A, Nanda A, Behera S. AKT3 and α-SMA in oral submucous fibrosis and oral squamous cell carcinoma with concomitant oral submucous fibrosis as potential prognostic indicators. Journal of Oral and Maxillofacial Pathology. 2026;30(2):186-193. doi:10.4103/jomfp.jomfp_400_25
BibTeX
@article{Behera2026,
author = {Behera, Sonali and Rath, Rachna and Das, Surya Narayan and Mohanty, Aishwarya and Nanda, Aakankshya and Behera, Sharmila},
title = {AKT3 and α-SMA in oral submucous fibrosis and oral squamous cell carcinoma with concomitant oral submucous fibrosis as potential prognostic indicators},
journal = {Journal of Oral and Maxillofacial Pathology},
year = {2026},
volume = {30},
number = {2},
pages = {186--193},
doi = {10.4103/jomfp.jomfp_400_25}
}
EUVIMED